Product Details
Source
Monoclonal Anti-HRSV F-hRSV90 Antibody, Human IgG1 is a recombinant chimeric monoclonal antibody expressed in HEK293, which combines the variable region of a mouse monoclonal antibody with human constant domain.
Antibody Type
Recombinant Monoclonal
Clone
hRSV90
Isotype
Human IgG1, Kappa
Specificity
This product is a specific antibody specifically reacts with HRSV F.
Application
ApplicationRecommended UsageELISA1:2000-1:20000Purification
Protein A purified / Protein G purified.
Aggregation
Less than 5%, as determined by SEC-MALS.
Concentration
Please refer to the Certificate of Analysis (CoA).
Form
Liquid
Formulation
Supplied a 0.22 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Storage
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 12 months under sterile conditions.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-ELISA

Immobilized HRSV (A) Pre-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H7) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-HRSV F-hRSV90 Antibody, Human IgG1 (Cat. No. HRV-M720) with a linear range of 0.03-1 ng/mL. HRSV (A) Post-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H6) is verified not recoginized by Monoclonal Anti-HRSV F-hRSV90 Antibody, Human IgG1 (Cat. No. HRV-M720) in low concentration (QC tested).
Protocol
Immobilized HRSV (B) Pre-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H8) at 1 μg/mL (100 μL/well) can bind Monoclonal Anti-HRSV F-hRSV90 Antibody, Human IgG1 (Cat. No. HRV-M720) with a linear range of 0.03-1 ng/mL. HRSV (B) Post-fusion glycoprotein F0, His Tag (Cat. No. RSF-V52H9) is verified not recoginized by Monoclonal Anti-HRSV F-hRSV90 Antibody, Human IgG1 (Cat. No. HRV-M720) in low concentration (Routinely tested).
Protocol
Customer Reviews Writing Reviews




















